Guanosine increases global SUMO1-ylation in the hippocampus of young and aged mice and improves the short-term memory of young mice

Camila A Zanella; Naiani Marques; Stella Junqueira; Rui D Prediger; Carla I Tasca; Helena I Cimarosti

doi:10.1111/jnc.15920

Guanosine increases global SUMO1-ylation in the hippocampus of young and aged mice and improves the short-term memory of young mice

J Neurochem. 2023 Jul 25. doi: 10.1111/jnc.15920. Online ahead of print.

Authors

Camila A Zanella¹, Naiani Marques², Stella Junqueira³, Rui D Prediger^{1

3}, Carla I Tasca^{2

3}, Helena I Cimarosti^{1

3}

Affiliations

¹ Pharmacology Department, Pharmacology Postgraduate Program, Biological Sciences Center (CCB), Federal University of Santa Catarina (UFSC), Florianópolis, Brazil.
² Biochemistry Department, Biochemistry Postgraduate Program, CCB, UFSC, Florianópolis, Brazil.
³ Neuroscience Postgraduate Program, CCB, UFSC, Florianópolis, Brazil.

PMID: 37491912
DOI: 10.1111/jnc.15920

Abstract

The nucleoside guanosine is an endogenous neuromodulator associated with neuroprotection. The roles of guanosine during aging are still not fully elucidated. Guanosine modulates SUMOylation in neurons and astrocytes in vitro, but it is not known whether guanosine can modulate SUMOylation in vivo and improve cognitive functions during aging. SUMOylation is a post-translational protein modification with potential neuroprotective roles. In this follow-up study, we investigated whether guanosine could modulate SUMOylation in vivo and behavior in young and aged mice. Young (3-month-old) and aged (24-month-old) C57BL/6 mice were treated with guanosine (8 mg/kg intraperitoneal) daily for 14 days. Starting on day 8 of treatment, the following behavioral tests were performed: open field, novel object location, Y-maze, sucrose splash test, and tail suspension test. Treatment with guanosine did not change the locomotor activity of young or aged mice in the open-field test. Treatment with guanosine improved short-term memory only for young mice but did not change the working memory of either young or aged mice, as evaluated using object recognition and the Y-maze tests, respectively. Depressive-like behaviors, such as impaired grooming evaluated through the splash test, did not change in either young or aged mice. However, young mice treated with guanosine increased their immobility time in the tail suspension test, suggesting an effect on behavioral coping strategies. Global SUMO1-ylation was significantly increased in the hippocampus of young and aged mice after 14 days of treatment with guanosine, whereas no changes were detected in the cerebral cortex of either young or aged mice. Our findings demonstrate that guanosine also targets hippocampal SUMOylation in vivo, thereby contributing to a deeper understanding of its mechanisms of action. This highlights the involvement of SUMOylation in guanosine's modulatory and neuroprotective effects.

Keywords: SUMO; aging; guanosine; memory; post-translational modification; purinergic system.

Abstract

Grants and funding